Alexion, Synageva BioPharma has June 15 antitrust deadline
MLex Summary: Alexion Pharmaceuticals and Synageva BioPharma filed paperwork seeking US antitrust approval for their planned $8.4 billion merger, according to a filing with the US Securities and Exchange Commission by Alexion on...To view the full article, register now.
Already a subscriber? Click here to view full article